基于实验室的衰弱指数预测系统性红斑狼疮长期健康结局的构建与评估
本研究在283例成人SLE前瞻性队列中构建并评估了首个基于实验室的衰弱指数(FI-Lab),以FI-Lab>0.21定义衰弱。衰弱患者全因死亡风险(HR 3.71,95%CI 1.82-7.54)和器官损害累积发生率(IRR 2.26,95%CI 1.59-3.22)均显著升高,且FI-Lab与SLICC-FI联合模型预测效能优于单一指数。
要点
- FI-Lab>0.21定义衰弱,与全因死亡和器官损害累积独立相关
- FI-Lab多变量调整后仍与死亡风险显著相关
- FI-Lab与SLICC-FI联合模型对器官损害预测优于单一指数
核心结论
- 仅基于常规实验室变量构建的FI-Lab可测量SLE患者衰弱并预测不良结局。
- FI-Lab可作为便捷筛查工具识别亚临床衰弱并促进早期风险干预。
研究设计与样本
- 单中心前瞻性队列研究,纳入2010至2019年基线访视的成人SLE患者283例。
- 构建30项FI-Lab,采用Cox比例风险回归分析全因死亡,负二项回归分析器官损害累积。
- 通过AIC、Harrell C统计量和伪R2比较含FI-Lab和/或SLICC-FI的多变量模型预测效能。
主要发现
- 283例患者中89%为女性,平均年龄47.7岁,97例(FI-Lab>0.21)在基线被归类为衰弱。
- 衰弱患者较非衰弱患者全因死亡风险升高(HR 3.71,95%CI 1.82-7.54)。
- 衰弱患者随访期间器官损害累积发生率更高(IRR 2.26,95%CI 1.59-3.22)。
- FI-Lab在多变量调整后仍与死亡风险显著相关。
- FI-Lab和SLICC-FI均为器官损害累积的显著基线预测因子,联合模型优于任一单独模型。
关键数值与推荐
- FI-Lab>0.21定义为衰弱,基于30项实验室变量构建。
- 衰弱与全因死亡关联的HR为3.71(95%CI 1.82-7.54)。
- 衰弱与器官损害累积关联的IRR为2.26(95%CI 1.59-3.22)。
临床怎么用
- 可利用常规实验室数据计算FI-Lab筛查SLE患者亚临床衰弱。
- FI-Lab>0.21提示死亡和器官损害风险升高,应加强风险监测与早期干预。
- 联合FI-Lab与SLICC-FI可能改善对器官损害累积的预测。
局限性
- 单中心前瞻性队列,样本量283例,外推性需进一步验证。
- FI-Lab为基于现有列表改编的30项指数,未在外部队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We aimed to construct and evaluate the first laboratory-based frailty index (FI-Lab) for predicting adverse outcomes in systemic lupus erythematosus (SLE) and to compare its predictive ability to that of an existing clinical FI. METHODS: We used data from a single-center prospective cohort of adult patients with SLE whose baseline visit occurred between 2010 and 2019. A 30-item FI-Lab was constructed by adapting an existing list of FI-Lab variables. Cox proportional hazards regression examined the association between baseline FI-Lab scores and all-cause mortality, whereas negative binomial regression evaluated the association with organ damage accrual. We compared the performance of multivariable models containing the FI-Lab and/or Systemic Lupus International Collaborating Clinics FI as predictor variables using Akaike information criterion, Harrell's C-statistic, and pseudo-R2 values. RESULTS: Among 283 patients (89% women, mean age 47.7 years), 97 were classified as frail at baseline (FI-Lab >0.21). Frail individuals had increased mortality risk (hazard ratio 3.71, 95% confidence interval [CI] 1.82-7.54) and a higher rate of organ damage accrual during follow-up (incidence rate ratio 2.26; 95% CI 1.59-3.22) compared to nonfrail patients. The FI-Lab remained significantly associated with mortality risk after multivariable adjustment. Although both indices were significant baseline predictors of organ damage accrual during follow-up, the multivariable model containing both FIs outperformed models containing either index alone. CONCLUSION: An FI constructed exclusively from routinely collected laboratory variables can measure frailty and predict adverse outcomes in SLE. It may serve as a convenient screening tool to detect subclinical frailty and promote early risk mitigation in this population.
引用
- Burns G, Searle SD, Legge A, et al. Developing and Evaluating a Laboratory-Based Frailty Index for the Prediction of Long-Term Health Outcomes in Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2026. PMID: 41801062. doi:10.1002/acr.80036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。